Explore ›
Finding
Finding
adverse
In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).
| Effect size | 8% at 1 month, 4% at 3 months, 2% at 6 months |
| Follow-up | 6 months |
| Comparator | Sacral neuromodulation (no catheterization required) |
| Effect summary | adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months |
| Adverse events | intermittent self-catheterization 8% at 1 month, 4% at 3 months, 2% at 6 months |
Connected entities
Conditions
Outcomes
Source
PMC5399419
OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women A Randomized Clinical Trial